NCT01147237

Xience/Promus for Long Coronary Lesion Registry

A Multi Center Registry to Evaluate Multiple Stenting Using by Everolimus-eluting Stents for Treatment of Long Coronary Artery Disease

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 450 (actual)
• Sponsor: Society for Advancement of Coronary Intervention Research · Network
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The utilization of everolimus-eluting coronary stents in a coronary artery diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of multiple everolimus-eluting coronary stent implantation in long (\>30mm) coronary lesions.

Conditions

• Long Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Intracoronary stent implantation	Everolimus-eluting stent implantation in patients with long coronary artery disease

Timeline

• Start date: 2010-02-01
• Primary completion: 2011-09-01
• Completion: 2012-12-01
• First posted: 2010-06-22
• Last updated: 2010-06-22

Locations

31 sites across 1 country: Japan